Modern Rheumatology · 2007 · 15 citations · 7 references
MedicineHematologyPharmacologyImmunopathologyImmunopharmacologyRheumatologyAnemiaAutoimmune Hematologic DiseaseHematologic ToxicityPneumonia PharmacotherapyRheumatoid ArthritisAnemia In Rheumatoid ArthritisBacterial Pneumonia TreatmentDrug-induced Cytopenia ManagementHypoxiaImmune-mediated CytopeniasNonspecific Interstitial PneumoniaProductive Cough ManagementRheumatoid Arthritis Pharmacotherapy
A female rheumatoid arthritis patient was admitted for productive cough and general fatigue that had gradually developed after leflunomide therapy. Side effects including severe hypoxia, thrombocytopenia, lymphocytopenia, and macrocytic anemia with schistocytes (probably drug-induced megaloblastic anemia) were noted. Leflunomide-eliminating cholestyramine therapy successfully treated all conditions excluding severe hypoxia, which occurred owing to deteriorating interstitial pneumonia and complicated bacterial pneumonia following antibiotic treatment. This is a rare case of leflunomide-associated multiple hematopoietic impairments.
7
Japan deaths spark concerns over arthritis drug
Justin McCurry · The Lancet · 2004 · 75 citations
Drug-induced Megaloblastic Change
John M. Scott, Donald G. Weir · Clinics in Haematology · 1980 · 71 citations
Leflunomide-Induced Pneumonitis in a Patient with Rheumatoid Arthritis
Yu Hirabayashi, H Shimizu, Nobuyuki Kobayashi et al. · Internal Medicine · 2006 · 42 citations · Full text